Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS academics to present papers at Conference on Calvin Research
2010-07-05

Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS, will be one of three UFS keynote speakers at the 10th International Congress on Calvin Research.
Photo: Provided


Three scholars from the University of the Free State (UFS) were invited to participate as keynote speakers at the 10th International Conference on Calvin Research that will be hosted by the UFS from 22-27 August 2010. 

“Hosting this conference is seen as an exceptional achievement since the conference represents an international, high-profiled and specialised research community where invitation to present research results is based on proven academic outputs, innovation and original research,” said Prof. Dolf Britz, Director: Jonathan Edwards Center Africa at the UFS. Prof. Britz will, as keynote speaker, present a paper on Calvin's exposition of a Biblical text that played a significant role in the ‘Freedom Struggle’ in South Africa.

The programme for the Conference on Calvin Research also provides for two workshops specially designed for postgraduate students. This will be facilitated by international scholars and the focus will be on research methodology and the academic competencies to write a dissertation.

A student from the UFS, Rev. Ntabanyane Tseuao, was selected to present a short paper at the conference. He is one of three postgraduate students who are from the Theological University Apeldoorn in the Netherlands and the University of Tübingen in Germany, respectively.

Prof. Erik de Boer, an Extraordinary Professor and Research Fellow at the UFS and Mr Eric Kayayan, a Research Fellow at the UFS, will also be keynote speakers at the conference.

Two other academics from the UFS, Prof. Adriaan Neele, an Extraordinary Professor and Research Fellow and Dr Victor d’Assonville, a Research Fellow, will also present papers.

The participation of these academics in the conference is the result of an initiative that started eight years ago to cluster South African research on Classical and Reformation Theology at the University of the Free State. - Leonie Bolleurs

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept